Heterotopic cardiac transplantation with a xenograft for assistance of the left heart in cardiogenic shock after cardiopulmonary bypass
- PMID: 416502
Heterotopic cardiac transplantation with a xenograft for assistance of the left heart in cardiogenic shock after cardiopulmonary bypass
Abstract
One of the indications for the use of the heterotopic cardiac transplant is temporarily to support a failing heart in the anticipation of its recovery when all other measures of support have been unsuccessful. Human donors are not always available when required and we decided to use a xenograft for this purpose when the need arose. This report details our experience with a baboon and a chimpanzee cardiac xenograft transplant in the heterotopic position. We have found (a) that the operation is technically feasible; (b) that the xenograft will support the failing circulation, but that the more support required, the bigger the xenograft should be and the species chosen accordingly; (c) that severe acute rejection will occur within 4 days and the procedure should therefore only be employed where there is evidence that the patient's own heart function will recover rapidly.
Similar articles
-
Elective femoro-femoral cardiopulmonary bypass during transcatheter aortic valve implantation: a useful tool.J Thorac Cardiovasc Surg. 2013 Mar;145(3):757-63. doi: 10.1016/j.jtcvs.2012.02.012. Epub 2012 Mar 9. J Thorac Cardiovasc Surg. 2013. PMID: 22405673
-
Operation for acute postinfarction mitral insufficiency and cardiogenic shock.J Thorac Cardiovasc Surg. 1985 Apr;89(4):525-30. J Thorac Cardiovasc Surg. 1985. PMID: 3872381
-
Xenograft heterotopic cardiac transplantation in cardiogenic shock.S Afr Med J. 1978 Mar 11;53(10):350. S Afr Med J. 1978. PMID: 653468 No abstract available.
-
Mechanical circulatory support in postoperative cardiogenic shock.J Thorac Cardiovasc Surg. 1978 Jan;75(1):97-103. J Thorac Cardiovasc Surg. 1978. PMID: 619182
-
[Patient-adapted valve selection: biological vs. mechanical heart valve replacement in aortic valve diseases].Z Kardiol. 2001;90 Suppl 6:48-57. Z Kardiol. 2001. PMID: 11826822 Review. German.
Cited by
-
Strategies for Expanding Donors Pool in Heart Transplantation.Rev Cardiovasc Med. 2022 Aug 15;23(8):285. doi: 10.31083/j.rcm2308285. eCollection 2022 Aug. Rev Cardiovasc Med. 2022. PMID: 39076623 Free PMC article. Review.
-
The history of cardiac xenotransplantation: early attempts, major advances, and current progress.Front Transplant. 2023 Jul 10;2:1125047. doi: 10.3389/frtra.2023.1125047. eCollection 2023. Front Transplant. 2023. PMID: 38993853 Free PMC article. Review.
-
How should cardiac xenotransplantation be initiated in Japan?Surg Today. 2024 Aug;54(8):829-838. doi: 10.1007/s00595-024-02861-7. Epub 2024 May 11. Surg Today. 2024. PMID: 38733536 Free PMC article. Review.
-
Enhancing Kidney Transplantation and the Role of Xenografts: Report of a Scientific Workshop Sponsored by the National Kidney Foundation.Am J Kidney Dis. 2024 Jul;84(1):94-101. doi: 10.1053/j.ajkd.2023.12.025. Epub 2024 Mar 5. Am J Kidney Dis. 2024. PMID: 38452918 Review.
-
The immunobiology and clinical use of genetically engineered porcine hearts for cardiac xenotransplantation.Nat Cardiovasc Res. 2022 Aug;1(8):715-726. doi: 10.1038/s44161-022-00112-x. Epub 2022 Aug 9. Nat Cardiovasc Res. 2022. PMID: 36895262 Free PMC article.